Announces Name Change; To Present at Nuclear Science Symposium

Zecotek Announces Name Change; To Present at Nuclear Science Symposium and Medical Imaging Conference

Vancouver, October 24, 2007 – Zecotek Medical Systems, Inc. (TSX-V: ZMS; Frankfurt: W1I.F) today announced that it has changed its name to Zecotek Photonics Inc. effective October 26, 2007. The name change better reflects the broad range of industries and applications of the company’s photonic product portfolio. The company will have a new CUSIP number: 98912P104 and will retain the TSX Venture Exchange stock symbol “ZMS”.

Zecotek also announced today the Company’s participation in the Nuclear Science Symposium (NSS) and Medical Imaging Conference taking place in Honolulu from October 29 through November 3, 2007. Dr. A. F. Zerrouk, Zecotek’s Chairman, President and Chief executive Officer will participate in Exhibitor Technical Sessions with a presentation on Zecotek’s latest photonic technologies. Zecotek will also display products and product information at a dedicated company booth.

The Nuclear Science Symposium offers an outstanding opportunity for scientists and engineers interested or actively working in the fields of nuclear science, radiation instrumentation, software and their applications, particle detector design, and the High-Energy Physics community to meet and discuss with colleagues from around the world. The program emphasizes the latest developments in technology and instrumentation and their implementation in experiments for space, accelerators, other radiation environments, and homeland security.

The Medical Imaging Conference is the longest standing and most respected international scientific meeting on the physics, engineering and mathematical aspects of x-ray and nuclear medicine based imaging. Each year significant innovations in all forms of medical and biomedical imaging are welcomed and presented, as x-ray, nuclear medicine (emission imaging and radioisotope therapy) and its technologies intersect and overlap with many arenas of medicine (e.g., Radiology, Cardiology, Neurology, Oncology) and their technologies. This conference is an excellent venue for communication and discussion of novel medical and biomedical imaging technologies and uses. Average attendance to previous NSS-MIC meetings has been approximately 1400.

About Zecotek
Zecotek Photonics Inc. (TSX-V: ZMS; Frankfurt: W1I) is a photonics technology company developing high-performance crystals, photo detectors, medical lasers, optical imaging and 3D display technologies for commercial applications in the medical diagnostics and high-tech industry. Founded in 2003, the company has three distinct operating divisions: imaging, lasers and 3D display and labs located in Canada, Singapore and Russia. Zecotek commercializes its novel, patented and patent-pending photonic technologies directly and through strategic alliances and joint ventures with multinational OEMs, distributors and other industry leaders. For more information, please visit Zecotek Photonics.

This press release may contain forward-looking statements that are based on management’s expectations, estimates, projections and assumptions. These statements are not guarantees of future performance and involve certain risks and uncertainties, which are difficult to predict. Therefore, actual future results and trends may differ materially from what may have been stated.

Zecotek Photonics Inc.

MICHAEL MINDER

CFO; VP Corporate Development

(604) 827-5203

Website: Zecotek Photonics

OR

Caliber Capital Partners

TIM MCNULTY

(778) 327-6678

Email: ir@zecotek.com

The TSX Venture Exchange has not reviewed and does not accept responsibility for the adequacy or accuracy of the content of this news release. If you would like to receive news from Zecotek in the future please visit the corporate website at Zecotek Photonics.

print